Dutch device company Gilbert Technologies has announced the closing of a €7 million funding round led by DeepTechXL. The company said that Brabant Startup Funds also converted its earlier loan to Gilbert Technologies, making Brabant a shareholder, along with current shareholders NanoCorp and Delft Enterprises.
According to Gilbert, the proceeds of the funding will go toward further development of its SMI platform, which is based on electro hydrodynamic atomization (EHDA) technology and delivers a monodisperse aerosol at a customizable particle size.
Gilbert CEO Maurits Huigen commented, “We are privileged that our new esteemed partners join us on our mission to redefine treatment for lung patients, together with our existing loyal shareholders. This financing round validates our vision to make medical treatment easier and more effective, to save lives and help patients live the life they want, while reducing the burden on healthcare systems. We are looking forward to the next wave of growth that lies ahead from becoming a clinical stage – towards commercial stage company by getting to key inflection points on the development of our investigational device and partnerships with pharmaceutical companies for our first drug-device combination.”
Read the Gilbert Technologies press release.
